Terms: = Uterine cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Staging
65 results:
1. Lymphatic Mapping and Sentinel Node Biopsy in High-Grade uterine cancers.
How JA; Frumovitz M; Stewart KI; Soliman PT
Curr Oncol Rep; 2022 Nov; 24(11):1521-1529. PubMed ID: 35781863
[TBL] [Abstract] [Full Text] [Related]
2. Advances in management of nonendometrioid endometrial carcinoma, with an emphasis on the sentinel lymph node technique.
Eriksson AGZ; Mueller JJ
Curr Opin Oncol; 2021 Sep; 33(5):457-463. PubMed ID: 34264897
[TBL] [Abstract] [Full Text] [Related]
3. Controversies in Sentinel Lymph Node Biopsy for Gynecologic Malignancies.
Rossi EC; Tanner E
J Minim Invasive Gynecol; 2021 Mar; 28(3):409-417. PubMed ID: 33359741
[TBL] [Abstract] [Full Text] [Related]
4. Treatment of gestational trophoblastic disease in the 2020s.
Clark JJ; Slater S; Seckl MJ
Curr Opin Obstet Gynecol; 2021 Feb; 33(1):7-12. PubMed ID: 33337613
[TBL] [Abstract] [Full Text] [Related]
5. Whole-Volume Tumor MRI Radiomics for Prognostic Modeling in Endometrial cancer.
Fasmer KE; Hodneland E; Dybvik JA; Wagner-Larsen K; Trovik J; Salvesen Ø; Krakstad C; Haldorsen IHS
J Magn Reson Imaging; 2021 Mar; 53(3):928-937. PubMed ID: 33200420
[TBL] [Abstract] [Full Text] [Related]
6. Novel T2 Mapping for Evaluating Cervical cancer Features by Providing Quantitative T2 Maps and Synthetic Morphologic Images: A Preliminary Study.
Li S; Liu J; Zhang F; Yang M; Zhang Z; Liu J; Zhang Y; Hilbert T; Kober T; Cheng J; Zhu J
J Magn Reson Imaging; 2020 Dec; 52(6):1859-1869. PubMed ID: 32798294
[TBL] [Abstract] [Full Text] [Related]
7. What Is the Role of Imaging at Primary Diagnostic Work-Up in uterine Cervical cancer?
Haldorsen IS; Lura N; Blaakær J; Fischerova D; Werner HMJ
Curr Oncol Rep; 2019 Jul; 21(9):77. PubMed ID: 31359169
[TBL] [Abstract] [Full Text] [Related]
8. Spectrum of Gynecological Malignancies at Jamshoro.
Parveen N; Sikander R; Majida ; Shaheen
J Coll Physicians Surg Pak; 2018 Jan; 28(1):52-55. PubMed ID: 29290193
[TBL] [Abstract] [Full Text] [Related]
9. Cyto-colpo-histologic correlation: about an analytical study of 120 colposcopies.
Slimani O; Ben Temim R; Makhlouf T; Mathlouthi N; Attia L
Tunis Med; 2016 Oct; 94(10):616-620. PubMed ID: 28972254
[TBL] [Abstract] [Full Text] [Related]
10. Cyto-colpo-histologic correlation: about an analytical study of 120 colposcopies.
Slimani O; Ben Temim R; Makhlouf T; Mathlouthi N; Attia L
Tunis Med; 2016 Oct; 94(8-9):616-620. PubMed ID: 28685798
[TBL] [Abstract] [Full Text] [Related]
11. Early Cervical cancer: Current Dilemmas of staging and Surgery.
Zigras T; Lennox G; Willows K; Covens A
Curr Oncol Rep; 2017 Aug; 19(8):51. PubMed ID: 28664470
[TBL] [Abstract] [Full Text] [Related]
12. Novel imaging techniques in gynaecological cancer.
Vandecaveye V; Dresen R; De Keyzer F
Curr Opin Oncol; 2017 Sep; 29(5):335-342. PubMed ID: 28594645
[TBL] [Abstract] [Full Text] [Related]
13. Treatment strategies for endometrial cancer: current practice and perspective.
Lee YC; Lheureux S; Oza AM
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):47-58. PubMed ID: 27941361
[TBL] [Abstract] [Full Text] [Related]
14. Vascular endothelial growth factor (VEGF) and cyclooxygenase 2 (COX 2) immunostaining in ovarian cancer.
Whynott RM; Manahan P; Geisler JP
Eur J Gynaecol Oncol; 2016; 37(2):164-6. PubMed ID: 27172738
[TBL] [Abstract] [Full Text] [Related]
15. How to improve the preoperative staging of presumed early-stage endometrioid endometrial cancer?
Bleu G; Arsène E; Merlot B; Kerdraon O; Bigot J; Boulanger L; Dedet B; Vinatier D; Collinet P
Eur J Gynaecol Oncol; 2015; 36(6):698-702. PubMed ID: 26775355
[TBL] [Abstract] [Full Text] [Related]
16. Intraoperative subserosal approach to label sentinel nodes in intermediate and high-risk endometrial cancer.
Valha P; Kucera E; Sak P; Stepanek O; Michal M
Eur J Gynaecol Oncol; 2015; 36(6):643-6. PubMed ID: 26775344
[TBL] [Abstract] [Full Text] [Related]
17. The opinion of gynecologists on the management of early-stage, high-grade endometrioid endometrial cancer.
Geels YP; van der Putten LJ; van der Steen-Banasik EM; Snijders MP; Massuger LF; Pijnenborg JM
Eur J Gynaecol Oncol; 2015; 36(4):402-5. PubMed ID: 26390691
[TBL] [Abstract] [Full Text] [Related]
18. Pathological factors associated with omental metastases in endometrial cancer.
Sakai K; Yamagami W; Susumu N; Nomura H; Kataoka F; Banno K; Tsuda H; Aoki D
Eur J Gynaecol Oncol; 2015; 36(4):397-401. PubMed ID: 26390690
[TBL] [Abstract] [Full Text] [Related]
19. Pain typology and incident endometriosis.
Schliep KC; Mumford SL; Peterson CM; Chen Z; Johnstone EB; Sharp HT; Stanford JB; Hammoud AO; Sun L; Buck Louis GM
Hum Reprod; 2015 Oct; 30(10):2427-38. PubMed ID: 26269529
[TBL] [Abstract] [Full Text] [Related]
20. The prognostic significance of pretreatment [18F]FDG-PET/CT imaging in patients with uterine cervical cancer: preliminary results.
Cho SH; Lim JY; Kim SN; Hong S; Chung HW; So Y; Kim WY; Lee SJ
Eur J Gynaecol Oncol; 2015; 36(1):30-5. PubMed ID: 25872331
[TBL] [Abstract] [Full Text] [Related]
[Next]
